Special Issue "Dosage Forms and Delivery Systems for Vaginal Therapy"


A special issue of Pharmaceutics (ISSN 1999-4923).

Deadline for manuscript submissions: closed (20 June 2014)

Special Issue Editor

Guest Editor
Prof. Dr. Natasa Skalko-Basnet
Drug Transport and Delivery Research Group, Department of Pharmacy, University of Tromsø, Universitetsveien 57, 9037 Tromsø, Norway
Website: http://uit.no/ansatte/organisasjon/ansatte/person?p_document_id=81380&p_dimension_id=88118
E-Mail: natasa.skalko-basnet@uit.no
Interests: drug delivery; nanomedicine; liposomes; skin therapy; vaginal therapy

Special Issue Information

Dear Colleagues,

The focus of this issue is on the challenges and promises of delivery systems for the drug therapy of vaginal diseases. In spite of advancements in drug delivery technologies, the vaginal route of drug administration remains a challenge in the development of novel drug therapies. Most of the delivery systems are aimed at improving the treatment of vaginal infections, including HIV prevention. Promising new approaches in design of drug delivery systems destined both for local therapy and systemic absorption, the role of system’s mucoadhesiveness, potential for drug targeting, industrial scale up and acceptability by patients will be discussed in this issue. In addition, potential toxicity issues and use of delivery systems in pregnancy, optimization of drug delivery in pre- and post-menopausal women will also be included.

Prof. Dr. Natasa Skalko-Basnet
Guest Editor


Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed Open Access quarterly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 500 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.


  • vagina
  • mucoadhesion
  • drug delivery
  • topical vaginal therapy
  • systemic therapy via vagina
  • nanopharmaceuticals

Published Papers (2 papers)

by ,  and
Pharmaceutics 2014, 6(3), 494-511; doi:10.3390/pharmaceutics6030494
Received: 4 July 2014; in revised form: 13 August 2014 / Accepted: 15 August 2014 / Published: 27 August 2014
Show/Hide Abstract | PDF Full-text (863 KB) | HTML Full-text | XML Full-text
abstract graphic

by ,  and
Pharmaceutics 2014, 6(3), 366-377; doi:10.3390/pharmaceutics6030366
Received: 15 April 2014; in revised form: 13 June 2014 / Accepted: 25 June 2014 / Published: 4 July 2014
Show/Hide Abstract | PDF Full-text (845 KB) | HTML Full-text | XML Full-text
abstract graphic

Last update: 12 December 2013

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert